Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

End 2026 More Than 880 HCV Treatment-Naïve Patients Enrolled Across 17 Countries Outside North America C-FORWARD and C-BEYOND Represent the First Global Phase 3 Head-to-Head Trials of Direct-Acting ...
Nasdaq

Atea Pharmaceuticals Announces Continued Advancement of Global Phase 3 HCV Program with Dosing of First Patient in C-FORWARD Outside North America

C-FORWARD is the Second Phase 3 Trial in the Global HCV Development Program; the First Phase 3 Trial, C-BEYOND, is Currently Enrolling Patients in the US and Canada Regimen has Potential Best-in-Class ...
Opinion

Dr. Michael C. Threatt Encourages Section 8 Programs to offer a Homeownership Program and Celebrate Homeownership Month

Dr. Michael C. Threatt urges Habitat for Humanity to partner with PHAs to expand HCV Homeownership nationwide, ...
Medscape

Drop in HIV/HCV Coinfections After Nationwide HCV Program

“Nevertheless, these findings highlight the importance of treatment adherence, regular follow-up, and targeted prevention in order to reach the WHO [World Health Organization] HCV elimination goals,” ...
Health Affairs

To Eliminate HCV Among Persons Who Use Drugs: Embrace The Complexity

If we truly want to eliminate hepatitis C among persons who use drugs, we must also commit to addressing the complex realities of their lived experience. Offering HCV testing at clinical, ...
Milwaukee Community Journal

HACM Completes Section 8 Housing Choice Voucher Waiting List Lottery

Lottery Establishes Official Waiting List for Future Housing Choice Voucher Assistance HACM has completed a random lottery to ...